Search - tctmd.com

Displaying 201 - 220 of 279

Sort: Relevancy | Date

Presentation TCT 2014

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

Presenter: John M. Lasala, Stuart J. Pocock, George Hanzel, MD

September 16, 2014

Presentation TCT 2014

TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX

Presenter: John M. Lasala, Stuart J. Pocock, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Presenter: Alok Saurav

September 16, 2014

Presentation TCT 2014

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Presenter: Deepak Bhatt

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

Complete revascularization in ischemic heart failure may improve patient survival

Presenter: Lukasz Pyka

September 16, 2014

Presentation TCT 2014

Vagal Nerve Neuromodulation for Ischemic HF Therapy

Presenter: Daniel Burkhoff, Felix Mahfoud, Jose Luis Assad-Morell, Sahil A. Parikh, Gaetano De Ferrari

September 15, 2014

Presentation TCT 2014

TCT 75: Complete Revascularization in Ischemic Heart Failure May Improve Patient Survival

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Lukasz Pyka

September 15, 2014

Presentation TCT 2014

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Ulrich Schaefer, MD

September 15, 2014

News Conference News TCT 2014

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

September 15, 2014

Presentation TCT 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Frank Litvack, Todd J. Brinton

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Conference News TCT 2013

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

November 03, 2013

Presentation TCT 2013

IV Fibrinolysis, the Mainstay of Acute Ischemic Stroke Therapy: Role and Outcomes and Failure in Large Vessel Occlusions

Presenter: Wade Smith

October 31, 2013

News Conference News TCT 2013

Thrombectomy Fails to Reduce Microvascular Obstruction in Non-STEMI

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Presentation TCT 2013

Trading off Ischemic vs. Hemorrhagic Complications of PCI: Implications for Drug and Vascular Access Decision-Making

Presenter: Roxana Mehran

October 30, 2013

Advertisement

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Complete revascularization in ischemic heart failure may improve patient survival

Vagal Nerve Neuromodulation for Ischemic HF Therapy

TCT 75: Complete Revascularization in Ischemic Heart Failure May Improve Patient Survival

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

PFO Closure for Stroke: A Call to Revise the Guidelines

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

IV Fibrinolysis, the Mainstay of Acute Ischemic Stroke Therapy: Role and Outcomes and Failure in Large Vessel Occlusions

Thrombectomy Fails to Reduce Microvascular Obstruction in Non-STEMI

OPTIMIZE: 3-Month DAPT Safe with ZES

Trading off Ischemic vs. Hemorrhagic Complications of PCI: Implications for Drug and Vascular Access Decision-Making

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content